Gene therapy for heart bypass patients
Part of Heart & circulation clinical trials.
This trial tests a gene therapy called XC001, given directly to the heart during bypass surgery, to help grow new blood vessels and improve blood flow to areas that cannot be fully fixed with surgery alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have blocked coronary arteries and are scheduled for bypass surgery (CABG), but your surgeon thinks some blockages may remain after surgery.
- Your heart's pumping strength (ejection fraction) is between 25% and 50%.
- You have not had a heart attack or stroke in the last 60 days.
- You have not been treated for cancer (except certain skin cancers) in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special balloon coated with medicine to treat blocked small arteries in the heart. It may help people who have new blockages and are getting a procedure to open those arteries.
This trial tests a study drug called EA-230 to see if it can help people recover faster after heart bypass surgery (CABG). If you are scheduled for a planned surgery with at least 3 bypass grafts, you may be able to join.
This trial tests a new gene therapy (XC001) delivered through a thin tube into your heart's blood vessels. It aims to grow new blood vessels to relieve chest pain in people with chronic angina who have no other treatment options.
This trial tests a man-made blood vessel (CTEV) as a new option for bypass grafts in people who need heart bypass surgery. It aims to see if the CTEV is safe and effective for improving blood flow to the heart.
This trial tests a new artificial blood vessel for heart bypass surgery. If you need a bypass and meet the health requirements, you may be able to receive this experimental graft.
This study tests a new way to connect a bypass graft during heart bypass surgery for people with blocked heart arteries. The goal is to see if the new graft can be safely placed and works well enough to improve outcomes compared with the standard approach.
Hear when a new Coronary Artery Disease (CAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.